Tower Research Capital LLC (Trc) Immuneering Corp Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Immuneering Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,067 shares of IMRX stock, worth $32,098. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,067
Previous 4,893
146.62%
Holding current value
$32,098
Previous $14,000
7.14%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding IMRX
# of Institutions
60Shares Held
9.65MCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.88MShares$5.01 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.07MShares$2.85 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny953KShares$2.54 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD859KShares$2.29 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY742KShares$1.97 Million0.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $70.2M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...